Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Clinical trial NCT01198626 · TERMINATED
Trial details
- NCT number
- NCT01198626
- Sponsor
- Furiex Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.